Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
Authors
Keywords
-
Journal
Viruses-Basel
Volume 12, Issue 5, Pages 518
Publisher
MDPI AG
Online
2020-05-08
DOI
10.3390/v12050518
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and fit-for-purpose verification of an LC-MS method for quantitation of hemagglutinin and neuraminidase proteins in influenza virus-like particle vaccine candidates
- (2020) Jingzhong Guo et al. ANALYTICAL BIOCHEMISTRY
- Research progress on human infection with avian influenza H7N9
- (2020) Xiaoxin Wu et al. Frontiers of Medicine
- Avian Influenza Human Infections at the Human-Animal Interface
- (2020) Damien A M Philippon et al. JOURNAL OF INFECTIOUS DISEASES
- Separation of influenza virus‐like particles from baculovirus by polymer‐grafted anion exchanger
- (2020) Katrin Reiter et al. JOURNAL OF SEPARATION SCIENCE
- Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles
- (2019) Young-Tae Lee et al. VIROLOGY
- Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus
- (2019) Mutsumi Ito et al. Viruses-Basel
- Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens
- (2019) Jiao Hu et al. ARCHIVES OF VIROLOGY
- Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development
- (2019) Jo-Yu Hong et al. ANTIVIRAL RESEARCH
- Membrane‐based approach for the downstream processing of influenza virus‐like particles
- (2019) Sofia B. Carvalho et al. Biotechnology Journal
- The re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, 2019
- (2019) Deshan Yu et al. Eurosurveillance
- Challenges in the development of egg-independent vaccines for influenza
- (2019) Claudia Maria Trombetta et al. Expert Review of Vaccines
- Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs
- (2019) Hae-Ji Kang et al. PLoS One
- Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF
- (2019) Alina Venereo-Sánchez et al. VACCINE
- Enhancing the Yield and Quality of Influenza Virus-like Particles (VLPs) Produced in Insect Cells by Inhibiting Cytopathic Effects of Matrix Protein M2
- (2019) Andrew J. Zak et al. ACS Synthetic Biology
- An Influenza A Vaccine Based on the Extracellular Domain of Matrix 2 Protein Protects BALB/C Mice Against H1N1 and H3N2
- (2019) Hui Kian Ong et al. Vaccines
- Intragastric delivery of recombinant Lactococcus lactis displaying ectodomain of influenza matrix protein 2 (M2e) and neuraminidase (NA) induced focused mucosal and systemic immune responses in chickens
- (2019) Aritraa Lahiri et al. MOLECULAR IMMUNOLOGY
- Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP preparation in limiting postinfluenza Staphylococcus aureus infections
- (2019) Miriam Klausberger et al. VACCINE
- Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies
- (2019) Sophie Buffin et al. VACCINE
- The Spodoptera frugiperda Sf9 cell line is a heterogeneous population of rhabdovirus-infected and virus-negative cells: Isolation and characterization of cell clones containing rhabdovirus X-gene variants and virus-negative cell clones
- (2019) Hailun Ma et al. VIROLOGY
- Process development for pandemic influenza VLP vaccine production using a baculovirus expression system
- (2019) Chia-Chun Lai et al. Journal of Biological Engineering
- Advances in influenza virus-like particles bioprocesses
- (2019) Laurent Durous et al. Expert Review of Vaccines
- Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine
- (2019) Ya Zhou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Intramuscular and intranasal immunization with an H7N9 influenza virus-like particle vaccine protects mice against lethal influenza virus challenge
- (2018) Zhiguang Ren et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Adventitious viruses in insect cell lines used for recombinant protein expression
- (2018) Christoph Geisler et al. PROTEIN EXPRESSION AND PURIFICATION
- Multi-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactone
- (2018) Peter Pushko et al. VACCINE
- Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy
- (2018) Brianne J. Lindsay et al. VACCINE
- The temporal distribution of new H7N9 avian influenza infections based on laboratory-confirmed cases in Mainland China, 2013–2017
- (2018) Zuiyuan Guo et al. Scientific Reports
- Cell culture-derived flu vaccine: Present and future
- (2018) Alberto Pérez Rubio et al. Human Vaccines & Immunotherapeutics
- Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview
- (2018) Ahmed Mostafa et al. Viruses-Basel
- Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization
- (2018) Dustin M. McCraw et al. Scientific Reports
- Comparative effectiveness of H7N9 vaccines in healthy individuals
- (2018) Dan Zheng et al. Human Vaccines & Immunotherapeutics
- Tackling a novel lethal virus: a focus on H7N9 vaccine development
- (2017) Irina Isakova-Sivak et al. Expert Review of Vaccines
- Process intensification for high yield production of influenza H1N1 Gag virus-like particles using an inducible HEK-293 stable cell line
- (2017) Alina Venereo-Sanchez et al. VACCINE
- Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages
- (2017) Alexander I. Makarkov et al. VACCINE
- Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
- (2017) Emily Jane Woo et al. VACCINE
- Newcastle disease virus (NDV) recombinant expressing the hemagglutinin of H7N9 avian influenza virus protects chickens against NDV and highly pathogenic avian influenza A (H7N9) virus challenges
- (2017) Zenglei Hu et al. VACCINE
- Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets
- (2017) Gale E. Smith et al. VIROLOGY
- Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens
- (2017) Peter Pushko et al. VIROLOGY
- Nanodiamond enhances immune responses in mice against recombinant HA/H7N9 protein
- (2017) Ngoc Bich Pham et al. JOURNAL OF NANOBIOTECHNOLOGY
- Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines
- (2017) Ariane C. Gomes et al. Frontiers in Immunology
- Multi-subtype influenza virus-like particles incorporated with flagellin and granulocyte-macrophage colony-stimulating factor for vaccine design
- (2016) Wen-Chun Liu et al. ANTIVIRAL RESEARCH
- A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
- (2016) Stéphane Pillet et al. CLINICAL IMMUNOLOGY
- Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice
- (2016) Lili Xu et al. VACCINE
- Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate
- (2016) Alina Venereo-Sanchez et al. VACCINE
- Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model
- (2016) Peter Pushko et al. VACCINE
- Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses
- (2016) Dan Zheng et al. VACCINE
- Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein
- (2016) Irina Tretyakova et al. VIROLOGY
- Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B
- (2016) Xin Gong et al. Emerging Microbes & Infections
- Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles
- (2015) Christopher Ladd Effio et al. Biotechnology Journal
- An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin
- (2015) Li Song et al. BMC BIOTECHNOLOGY
- Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems
- (2015) Christine M Thompson et al. BMC BIOTECHNOLOGY
- Isolation and characteristic analysis of a novel strain H7N9 of avian influenza virus A from a patient with influenza-like symptoms in China
- (2015) Faming Chen et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Newcastle Disease Virus-Vectored H7 and H5 Live Vaccines Protect Chickens from Challenge with H7N9 or H5N1 Avian Influenza Viruses
- (2015) Qinfang Liu et al. JOURNAL OF VIROLOGY
- Characterization of Influenza A (H7N9) Viruses Isolated from Human Cases Imported into Taiwan
- (2015) Ji-Rong Yang et al. PLoS One
- Efficacy of a Parainfluenza Virus 5 (PIV5)-Based H7N9 Vaccine in Mice and Guinea Pigs: Antibody Titer towards HA Was Not a Good Indicator for Protection
- (2015) Zhuo Li et al. PLoS One
- Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus
- (2015) Peter Pushko et al. VACCINE
- ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans
- (2015) Ka Yan Chung et al. VACCINE
- Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge
- (2015) Brock Kingstad-Bakke et al. VACCINE
- Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets
- (2015) S. Pillet et al. VACCINE
- Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets
- (2015) Ye V. Liu et al. VACCINE
- Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice
- (2015) Li Zhang et al. Viruses-Basel
- An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
- (2015) Louis M. Schwartzman et al. mBio
- Mammalian adaptation of influenza A(H7N9) virus is limited by a narrow genetic bottleneck
- (2015) Hassan Zaraket et al. Nature Communications
- Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus
- (2015) Zhe Chen et al. Nature Communications
- Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine
- (2015) Changgui Li et al. Human Vaccines & Immunotherapeutics
- Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles
- (2015) Christopher Ladd Effio et al. Biotechnology Journal
- Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype
- (2015) V. Vamsee Aditya Mallajosyula et al. Frontiers in Immunology
- Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge
- (2015) Falko Schmeisser et al. PLoS One
- Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes
- (2014) Mookkan Prabakaran et al. ANTIVIRAL RESEARCH
- Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss
- (2014) Kathleen M Holtz et al. BMC BIOTECHNOLOGY
- Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge
- (2014) F. Krammer et al. JOURNAL OF VIROLOGY
- Biochemical composition of haemagglutinin-based influenza virus-like particle vaccine produced by transient expression in tobacco plants
- (2014) François Le Mauff et al. PLANT BIOTECHNOLOGY JOURNAL
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
- (2014) A. H. Ellebedy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus
- (2014) Juan Pu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Virus sharing, genetic sequencing, and global health security
- (2014) L. O. Gostin et al. SCIENCE
- Technology transfer and scale-up of the Flublok® recombinant hemagglutinin (HA) influenza vaccine manufacturing process
- (2014) Barry Buckland et al. VACCINE
- Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection
- (2013) Min-Chul Kim et al. ANTIVIRAL RESEARCH
- Induction of Cross-Reactive Antibodies to Novel H7N9 Influenza Virus by Recombinant Newcastle Disease Virus Expressing a North American Lineage H7 Subtype Hemagglutinin
- (2013) P. H. Goff et al. JOURNAL OF VIROLOGY
- A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine
- (2013) Louis F. Fries et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
- (2013) Rongbao Gao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthetic Generation of Influenza Vaccine Viruses for Rapid Response to Pandemics
- (2013) P. R. Dormitzer et al. Science Translational Medicine
- Development of influenza H7N9 virus like particle (VLP) vaccine: Homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus
- (2013) Gale E. Smith et al. VACCINE
- One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge
- (2013) Miriam Klausberger et al. VACCINE
- Mucosal Adjuvants for Influenza Virus-Like Particle Vaccine
- (2013) Fu-Shi Quan et al. VIRAL IMMUNOLOGY
- Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses
- (2013) Irina Tretyakova et al. VIROLOGY
- Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
- (2013) Christine M Thompson et al. Virology Journal
- Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System
- (2013) Irina Margine et al. Jove-Journal of Visualized Experiments
- Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection
- (2012) Fu-Shi Quan et al. VIROLOGY
- Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
- (2011) Michael T Osterholm et al. LANCET INFECTIOUS DISEASES
- A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus
- (2011) Glendie Marcelin et al. PLoS One
- Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines
- (2011) Hung-Ju Wei et al. VACCINE
- Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice
- (2011) Kirsten Schneider-Ohrum et al. VACCINE
- Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes
- (2011) Peter Pushko et al. VACCINE
- Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice
- (2010) Fu-Shi Quan et al. PLoS One
- Hemagglutinin Displayed Baculovirus Protects Against Highly Pathogenic Influenza
- (2010) Xian-Chun Tang et al. VACCINE
- Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge
- (2009) L. A. Perrone et al. JOURNAL OF VIROLOGY
- A Trivalent Virus-Like Particle Vaccine Elicits Protective Immune Responses against Seasonal Influenza Strains in Mice and Ferrets
- (2009) Ted M. Ross et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search